SLP
Simulations Plus, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$18.44
+0.00%Sep 17, 2026, 21:45 UTC
Simulations Plus announced that the U.S. Food and Drug Administration's Cosmetics Regulatory Science Branch licensed its ADMET Predictor software to support computational research for cosmetic safety assessment.
Source:Sep 10, 2026, 14:52 UTC
Johnson Fistel, PLLP announced an investigation into Simulations Plus, Inc. on behalf of investors who suffered losses, following the company's revenue guidance cut and accounting disclosures.
Aug 13, 2026, 21:00 UTC
Simulations Plus announced the expiration of the Hart-Scott-Rodino waiting period for its pending acquisition by Altaris, satisfying one regulatory condition.
Aug 13, 2026, 07:34 UTC
Dimensional Fund Advisors LP reduced its stake in Simulations Plus, Inc. by 15.6% during the quarter, selling 54,294 shares, leaving 293,940 shares, as disclosed in a Form 13F filing.
Source:Jun 17, 2026, 00:00 UTC
Simulations Plus, Inc. agreed to be acquired by SP Evolution HoldCo II, LLC, an affiliate of Altaris, LLC, in a reverse triangular merger where each share will be converted into $18.50 cash.